Genelux Corporation (NASDAQ: GNLX)
$2.58
-0.0400 ( -1.53% ) 17.0K
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
Market Data
Open
$2.58
Previous close
$2.62
Volume
17.0K
Market cap
$87.59M
Day range
$2.54 - $2.66
52 week range
$1.71 - $30.44
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Sep 27, 2023 |
4 | Insider transactions | 1 | Sep 27, 2023 |
4 | Insider transactions | 1 | Sep 25, 2023 |
4 | Insider transactions | 1 | Sep 21, 2023 |
4 | Insider transactions | 1 | Sep 21, 2023 |
4 | Insider transactions | 1 | Sep 20, 2023 |
4 | Insider transactions | 1 | Sep 18, 2023 |
4 | Insider transactions | 1 | Sep 18, 2023 |
4 | Insider transactions | 1 | Sep 15, 2023 |
4 | Insider transactions | 1 | Sep 15, 2023 |